Finance

Lists
KRRO:NASDAQ
Korro Bio Inc
US$ १४.७५
+०.१४%
(+०.०२०) 1D
US$ १४.७५
०.००% (०.००)
After hours
Closed: नोभेम्बर ६, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
US$ १४.७४
High
US$ १५.७४
Low
US$ १४.६९
Mkt. cap
२१.७२ करोड
Avg. vol.
२.०६ लाख
Volume
१.२३ लाख
52-wk high
US$ ३६.७९
52-wk low
US$ ५.२०
EPS
-US$ १०.००
Beta
३.२३
Shares outstanding
१.४७ करोड
No. of employees
५७
Open
US$ १४.७४
High
US$ १५.७४
Low
US$ १४.६९
Mkt. cap
२१.७२ करोड
Avg. vol.
२.०६ लाख
Volume
१.२३ लाख
52-wk high
US$ ३६.७९
52-wk low
US$ ५.२०
EPS
-US$ १०.००
Beta
३.२३
Shares outstanding
१.४७ करोड
No. of employees
५७
News stories
From web sources and news partners
About Korro Bio Inc
CEO-
Employees५७
Founded२०१४
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 6 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current US$ १४.७५
US$ ३०.०० (+१०३.३९%)
Average
US$ १९.८३ (+३४.४४%)
Lowest
US$ १०.०० (-३२.२०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luca Issi
RBC Capital
Hold
Maintained
US$ १०.००
-३२.२%
11/05/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
US$ २१.००
+४२.४%
11/05/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ १५.००
+१.७%
11/06/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
US$ २२.००
+४९.२%
10/28/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ३०.००
+१०३.४%
10/06/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
US$ २१.००
+४२.४%
10/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
US$ २२.००
+४९.२%
10/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$ २२.००
+४९.२%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
US$ १८.००
+२२%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
US$ १५.००
+१.७%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
US$ २३.००
+५५.९%
05/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
US$ २३.००
+५५.९%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१२.९२ लाख
-
-
-
Cost of goods sold
८५.९९ लाख
१.१५ करोड
१.१६ करोड
-
Cost of revenue
८५.९९ लाख
१.१५ करोड
१.१६ करोड
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
८५.७६ लाख
८९.०६ लाख
८४.७९ लाख
-
Operating expense
८५.७६ लाख
८९.०६ लाख
८४.७९ लाख
-
Total operating expenses
१.७२ करोड
२.०४ करोड
२.०१ करोड
-
Operating income
-१.५९ करोड
-२.०४ करोड
-२.०१ करोड
-
Other non operating income
९.९० लाख
-
-
-
EBT including unusual items
-४.९४ करोड
-१.९५ करोड
-१.८८ करोड
-
EBT excluding unusual items
-१.४९ करोड
-१.९५ करोड
-१.८८ करोड
-
Income tax expense
६.३६ लाख
९५.०० हजार
१.०८ लाख
-
Effective tax rate
-१.२९%
-०.४९%
-०.५७%
-
Other operating expenses
-
-
-
-
Net income
-५.०० करोड
-१.९६ करोड
-१.८९ करोड
-
Net profit margin
-३,८७३.२२%
-
-
-
Earnings per share
-१.६५
-१.६९
-१.०७
-०.९८
Interest and investment income
-
९.०६ लाख
१३.०२ लाख
-
Interest expense
-
-
-
-
Net interest expenses
-
९.०६ लाख
१३.०२ लाख
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.५२ करोड
-२.०१ करोड
-१.९७ करोड
-
Gain or loss from assets sale
-१८.०० हजार
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू